Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 5 of 8 for:    Breast Cancer | syndax [Lead]

Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02708680
Recruitment Status : Unknown
Verified October 2018 by Syndax Pharmaceuticals.
Recruitment status was:  Active, not recruiting
First Posted : March 15, 2016
Last Update Posted : October 26, 2018
Roche Pharma AG
Information provided by (Responsible Party):
Syndax Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : January 2019
Estimated Study Completion Date : January 2020